TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Axovant Sciences Ltd (NASDAQ:AXON) Investor Investigation Concerning Potential Securities Laws Violations Announced

  • If you purchased shares of Axovant Sciences Ltd (NASDAQ:AXON), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Axovant Sciences Ltd
Security
NASDAQ: AXON

Summary

An investigation on behalf of investors of Axovant Sciences Ltd (NASDAQ:AXON) shares over potential securities laws violations by Axovant Sciences and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Axovant Sciences Ltd (NASDAQ:AXON) concerning whether a series of statements by Axovant Sciences Ltd regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

London based Axovant Sciences Ltd. is a clinical-stage biopharmaceutical company that is focused on acquiring, developing and commercializing therapeutics for the treatment of dementia, including Alzheimer's disease and Lewy body dementia. Shares of Axovant Sciences Ltd (NASDAQ:AXON) declined from $24.99 per share in September 2017 to as low as $2.03 per share on January 16, 2018.

Start Monitoring Your Investments